Integrated heart/cancer on a chip to reproduce the side effects of anti-cancer drugs in vitro

Abstract

Integrated Heart/Cancer on a Chip (iHCC) is a promising microfluidic platform that allows the culture of different cell types separately and application of closed-medium circulation to reproduce the side effects of doxorubicin on heart <italic>in vitro</italic>.